Global Pemetrexed Injection Market Research Report 2024(Status and Outlook)
Report Overview
Pemetrexed is an antifolate agent with pyrrolidine pyrimidine group at its core. It can inhibit the growth of tumor by disrupting the normal folate dependent metabolic process in cells and inhibiting cell replication.
This report provides a deep insight into the global Pemetrexed Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pemetrexed Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pemetrexed Injection market in any manner.
Global Pemetrexed Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eagle Pharmaceuticals
AuroMedics Pharma
Teva Pharmaceutical Industries
Taro Pharma
Seacross Pharmaceuticals
Simcere Pharmaceutical Group
Qilu Pharmaceutical
Pfizer
Jiangsu Anda Pharmaceutical
Yangtze River Pharmaceutical Group
Hansoh Pharmaceutical Group Company
Nanjing Pharmaceutical Factory
DEYAO PHARMA
Vianex S.A.-Plant C
Hainan Jinrui Pharmaceutical
Market Segmentation (by Type)
0.5g Bottle
0.2g Bottle
Market Segmentation (by Application)
Non Squamous Non-Small Cell Lung Cancer
Squamous Cell Non-Small Cell Lung Cancer
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Pemetrexed Injection Market
%li%Overview of the regional outlook of the Pemetrexed Injection Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pemetrexed Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Pemetrexed is an antifolate agent with pyrrolidine pyrimidine group at its core. It can inhibit the growth of tumor by disrupting the normal folate dependent metabolic process in cells and inhibiting cell replication.
This report provides a deep insight into the global Pemetrexed Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pemetrexed Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pemetrexed Injection market in any manner.
Global Pemetrexed Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eagle Pharmaceuticals
AuroMedics Pharma
Teva Pharmaceutical Industries
Taro Pharma
Seacross Pharmaceuticals
Simcere Pharmaceutical Group
Qilu Pharmaceutical
Pfizer
Jiangsu Anda Pharmaceutical
Yangtze River Pharmaceutical Group
Hansoh Pharmaceutical Group Company
Nanjing Pharmaceutical Factory
DEYAO PHARMA
Vianex S.A.-Plant C
Hainan Jinrui Pharmaceutical
Market Segmentation (by Type)
0.5g Bottle
0.2g Bottle
Market Segmentation (by Application)
Non Squamous Non-Small Cell Lung Cancer
Squamous Cell Non-Small Cell Lung Cancer
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Pemetrexed Injection Market
%li%Overview of the regional outlook of the Pemetrexed Injection Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pemetrexed Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pemetrexed Injection
1.2 Key Market Segments
1.2.1 Pemetrexed Injection Segment by Type
1.2.2 Pemetrexed Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEMETREXED INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pemetrexed Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pemetrexed Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEMETREXED INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Pemetrexed Injection Sales by Manufacturers (2019-2024)
3.2 Global Pemetrexed Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pemetrexed Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pemetrexed Injection Sales Sites, Area Served, Product Type
3.6 Pemetrexed Injection Market Competitive Situation and Trends
3.6.1 Pemetrexed Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pemetrexed Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PEMETREXED INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Pemetrexed Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEMETREXED INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PEMETREXED INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pemetrexed Injection Sales Market Share by Type (2019-2024)
6.3 Global Pemetrexed Injection Market Size Market Share by Type (2019-2024)
6.4 Global Pemetrexed Injection Price by Type (2019-2024)
7 PEMETREXED INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pemetrexed Injection Market Sales by Application (2019-2024)
7.3 Global Pemetrexed Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Pemetrexed Injection Sales Growth Rate by Application (2019-2024)
8 PEMETREXED INJECTION MARKET SEGMENTATION BY REGION
8.1 Global Pemetrexed Injection Sales by Region
8.1.1 Global Pemetrexed Injection Sales by Region
8.1.2 Global Pemetrexed Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Pemetrexed Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pemetrexed Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pemetrexed Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pemetrexed Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pemetrexed Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eagle Pharmaceuticals
9.1.1 Eagle Pharmaceuticals Pemetrexed Injection Basic Information
9.1.2 Eagle Pharmaceuticals Pemetrexed Injection Product Overview
9.1.3 Eagle Pharmaceuticals Pemetrexed Injection Product Market Performance
9.1.4 Eagle Pharmaceuticals Business Overview
9.1.5 Eagle Pharmaceuticals Pemetrexed Injection SWOT Analysis
9.1.6 Eagle Pharmaceuticals Recent Developments
9.2 AuroMedics Pharma
9.2.1 AuroMedics Pharma Pemetrexed Injection Basic Information
9.2.2 AuroMedics Pharma Pemetrexed Injection Product Overview
9.2.3 AuroMedics Pharma Pemetrexed Injection Product Market Performance
9.2.4 AuroMedics Pharma Business Overview
9.2.5 AuroMedics Pharma Pemetrexed Injection SWOT Analysis
9.2.6 AuroMedics Pharma Recent Developments
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Pemetrexed Injection Basic Information
9.3.2 Teva Pharmaceutical Industries Pemetrexed Injection Product Overview
9.3.3 Teva Pharmaceutical Industries Pemetrexed Injection Product Market Performance
9.3.4 Teva Pharmaceutical Industries Pemetrexed Injection SWOT Analysis
9.3.5 Teva Pharmaceutical Industries Business Overview
9.3.6 Teva Pharmaceutical Industries Recent Developments
9.4 Taro Pharma
9.4.1 Taro Pharma Pemetrexed Injection Basic Information
9.4.2 Taro Pharma Pemetrexed Injection Product Overview
9.4.3 Taro Pharma Pemetrexed Injection Product Market Performance
9.4.4 Taro Pharma Business Overview
9.4.5 Taro Pharma Recent Developments
9.5 Seacross Pharmaceuticals
9.5.1 Seacross Pharmaceuticals Pemetrexed Injection Basic Information
9.5.2 Seacross Pharmaceuticals Pemetrexed Injection Product Overview
9.5.3 Seacross Pharmaceuticals Pemetrexed Injection Product Market Performance
9.5.4 Seacross Pharmaceuticals Business Overview
9.5.5 Seacross Pharmaceuticals Recent Developments
9.6 Simcere Pharmaceutical Group
9.6.1 Simcere Pharmaceutical Group Pemetrexed Injection Basic Information
9.6.2 Simcere Pharmaceutical Group Pemetrexed Injection Product Overview
9.6.3 Simcere Pharmaceutical Group Pemetrexed Injection Product Market Performance
9.6.4 Simcere Pharmaceutical Group Business Overview
9.6.5 Simcere Pharmaceutical Group Recent Developments
9.7 Qilu Pharmaceutical
9.7.1 Qilu Pharmaceutical Pemetrexed Injection Basic Information
9.7.2 Qilu Pharmaceutical Pemetrexed Injection Product Overview
9.7.3 Qilu Pharmaceutical Pemetrexed Injection Product Market Performance
9.7.4 Qilu Pharmaceutical Business Overview
9.7.5 Qilu Pharmaceutical Recent Developments
9.8 Pfizer
9.8.1 Pfizer Pemetrexed Injection Basic Information
9.8.2 Pfizer Pemetrexed Injection Product Overview
9.8.3 Pfizer Pemetrexed Injection Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Jiangsu Anda Pharmaceutical
9.9.1 Jiangsu Anda Pharmaceutical Pemetrexed Injection Basic Information
9.9.2 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Overview
9.9.3 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Market Performance
9.9.4 Jiangsu Anda Pharmaceutical Business Overview
9.9.5 Jiangsu Anda Pharmaceutical Recent Developments
9.10 Yangtze River Pharmaceutical Group
9.10.1 Yangtze River Pharmaceutical Group Pemetrexed Injection Basic Information
9.10.2 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Overview
9.10.3 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Market Performance
9.10.4 Yangtze River Pharmaceutical Group Business Overview
9.10.5 Yangtze River Pharmaceutical Group Recent Developments
9.11 Hansoh Pharmaceutical Group Company
9.11.1 Hansoh Pharmaceutical Group Company Pemetrexed Injection Basic Information
9.11.2 Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Overview
9.11.3 Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Market Performance
9.11.4 Hansoh Pharmaceutical Group Company Business Overview
9.11.5 Hansoh Pharmaceutical Group Company Recent Developments
9.12 Nanjing Pharmaceutical Factory
9.12.1 Nanjing Pharmaceutical Factory Pemetrexed Injection Basic Information
9.12.2 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Overview
9.12.3 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Market Performance
9.12.4 Nanjing Pharmaceutical Factory Business Overview
9.12.5 Nanjing Pharmaceutical Factory Recent Developments
9.13 DEYAO PHARMA
9.13.1 DEYAO PHARMA Pemetrexed Injection Basic Information
9.13.2 DEYAO PHARMA Pemetrexed Injection Product Overview
9.13.3 DEYAO PHARMA Pemetrexed Injection Product Market Performance
9.13.4 DEYAO PHARMA Business Overview
9.13.5 DEYAO PHARMA Recent Developments
9.14 Vianex S.A.-Plant C
9.14.1 Vianex S.A.-Plant C Pemetrexed Injection Basic Information
9.14.2 Vianex S.A.-Plant C Pemetrexed Injection Product Overview
9.14.3 Vianex S.A.-Plant C Pemetrexed Injection Product Market Performance
9.14.4 Vianex S.A.-Plant C Business Overview
9.14.5 Vianex S.A.-Plant C Recent Developments
9.15 Hainan Jinrui Pharmaceutical
9.15.1 Hainan Jinrui Pharmaceutical Pemetrexed Injection Basic Information
9.15.2 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Overview
9.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Market Performance
9.15.4 Hainan Jinrui Pharmaceutical Business Overview
9.15.5 Hainan Jinrui Pharmaceutical Recent Developments
10 PEMETREXED INJECTION MARKET FORECAST BY REGION
10.1 Global Pemetrexed Injection Market Size Forecast
10.2 Global Pemetrexed Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pemetrexed Injection Market Size Forecast by Country
10.2.3 Asia Pacific Pemetrexed Injection Market Size Forecast by Region
10.2.4 South America Pemetrexed Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pemetrexed Injection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pemetrexed Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pemetrexed Injection by Type (2025-2030)
11.1.2 Global Pemetrexed Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pemetrexed Injection by Type (2025-2030)
11.2 Global Pemetrexed Injection Market Forecast by Application (2025-2030)
11.2.1 Global Pemetrexed Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Pemetrexed Injection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pemetrexed Injection
1.2 Key Market Segments
1.2.1 Pemetrexed Injection Segment by Type
1.2.2 Pemetrexed Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEMETREXED INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pemetrexed Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pemetrexed Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEMETREXED INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Pemetrexed Injection Sales by Manufacturers (2019-2024)
3.2 Global Pemetrexed Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pemetrexed Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pemetrexed Injection Sales Sites, Area Served, Product Type
3.6 Pemetrexed Injection Market Competitive Situation and Trends
3.6.1 Pemetrexed Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pemetrexed Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PEMETREXED INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Pemetrexed Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEMETREXED INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PEMETREXED INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pemetrexed Injection Sales Market Share by Type (2019-2024)
6.3 Global Pemetrexed Injection Market Size Market Share by Type (2019-2024)
6.4 Global Pemetrexed Injection Price by Type (2019-2024)
7 PEMETREXED INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pemetrexed Injection Market Sales by Application (2019-2024)
7.3 Global Pemetrexed Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Pemetrexed Injection Sales Growth Rate by Application (2019-2024)
8 PEMETREXED INJECTION MARKET SEGMENTATION BY REGION
8.1 Global Pemetrexed Injection Sales by Region
8.1.1 Global Pemetrexed Injection Sales by Region
8.1.2 Global Pemetrexed Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Pemetrexed Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pemetrexed Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pemetrexed Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pemetrexed Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pemetrexed Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eagle Pharmaceuticals
9.1.1 Eagle Pharmaceuticals Pemetrexed Injection Basic Information
9.1.2 Eagle Pharmaceuticals Pemetrexed Injection Product Overview
9.1.3 Eagle Pharmaceuticals Pemetrexed Injection Product Market Performance
9.1.4 Eagle Pharmaceuticals Business Overview
9.1.5 Eagle Pharmaceuticals Pemetrexed Injection SWOT Analysis
9.1.6 Eagle Pharmaceuticals Recent Developments
9.2 AuroMedics Pharma
9.2.1 AuroMedics Pharma Pemetrexed Injection Basic Information
9.2.2 AuroMedics Pharma Pemetrexed Injection Product Overview
9.2.3 AuroMedics Pharma Pemetrexed Injection Product Market Performance
9.2.4 AuroMedics Pharma Business Overview
9.2.5 AuroMedics Pharma Pemetrexed Injection SWOT Analysis
9.2.6 AuroMedics Pharma Recent Developments
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Pemetrexed Injection Basic Information
9.3.2 Teva Pharmaceutical Industries Pemetrexed Injection Product Overview
9.3.3 Teva Pharmaceutical Industries Pemetrexed Injection Product Market Performance
9.3.4 Teva Pharmaceutical Industries Pemetrexed Injection SWOT Analysis
9.3.5 Teva Pharmaceutical Industries Business Overview
9.3.6 Teva Pharmaceutical Industries Recent Developments
9.4 Taro Pharma
9.4.1 Taro Pharma Pemetrexed Injection Basic Information
9.4.2 Taro Pharma Pemetrexed Injection Product Overview
9.4.3 Taro Pharma Pemetrexed Injection Product Market Performance
9.4.4 Taro Pharma Business Overview
9.4.5 Taro Pharma Recent Developments
9.5 Seacross Pharmaceuticals
9.5.1 Seacross Pharmaceuticals Pemetrexed Injection Basic Information
9.5.2 Seacross Pharmaceuticals Pemetrexed Injection Product Overview
9.5.3 Seacross Pharmaceuticals Pemetrexed Injection Product Market Performance
9.5.4 Seacross Pharmaceuticals Business Overview
9.5.5 Seacross Pharmaceuticals Recent Developments
9.6 Simcere Pharmaceutical Group
9.6.1 Simcere Pharmaceutical Group Pemetrexed Injection Basic Information
9.6.2 Simcere Pharmaceutical Group Pemetrexed Injection Product Overview
9.6.3 Simcere Pharmaceutical Group Pemetrexed Injection Product Market Performance
9.6.4 Simcere Pharmaceutical Group Business Overview
9.6.5 Simcere Pharmaceutical Group Recent Developments
9.7 Qilu Pharmaceutical
9.7.1 Qilu Pharmaceutical Pemetrexed Injection Basic Information
9.7.2 Qilu Pharmaceutical Pemetrexed Injection Product Overview
9.7.3 Qilu Pharmaceutical Pemetrexed Injection Product Market Performance
9.7.4 Qilu Pharmaceutical Business Overview
9.7.5 Qilu Pharmaceutical Recent Developments
9.8 Pfizer
9.8.1 Pfizer Pemetrexed Injection Basic Information
9.8.2 Pfizer Pemetrexed Injection Product Overview
9.8.3 Pfizer Pemetrexed Injection Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Jiangsu Anda Pharmaceutical
9.9.1 Jiangsu Anda Pharmaceutical Pemetrexed Injection Basic Information
9.9.2 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Overview
9.9.3 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Market Performance
9.9.4 Jiangsu Anda Pharmaceutical Business Overview
9.9.5 Jiangsu Anda Pharmaceutical Recent Developments
9.10 Yangtze River Pharmaceutical Group
9.10.1 Yangtze River Pharmaceutical Group Pemetrexed Injection Basic Information
9.10.2 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Overview
9.10.3 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Market Performance
9.10.4 Yangtze River Pharmaceutical Group Business Overview
9.10.5 Yangtze River Pharmaceutical Group Recent Developments
9.11 Hansoh Pharmaceutical Group Company
9.11.1 Hansoh Pharmaceutical Group Company Pemetrexed Injection Basic Information
9.11.2 Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Overview
9.11.3 Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Market Performance
9.11.4 Hansoh Pharmaceutical Group Company Business Overview
9.11.5 Hansoh Pharmaceutical Group Company Recent Developments
9.12 Nanjing Pharmaceutical Factory
9.12.1 Nanjing Pharmaceutical Factory Pemetrexed Injection Basic Information
9.12.2 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Overview
9.12.3 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Market Performance
9.12.4 Nanjing Pharmaceutical Factory Business Overview
9.12.5 Nanjing Pharmaceutical Factory Recent Developments
9.13 DEYAO PHARMA
9.13.1 DEYAO PHARMA Pemetrexed Injection Basic Information
9.13.2 DEYAO PHARMA Pemetrexed Injection Product Overview
9.13.3 DEYAO PHARMA Pemetrexed Injection Product Market Performance
9.13.4 DEYAO PHARMA Business Overview
9.13.5 DEYAO PHARMA Recent Developments
9.14 Vianex S.A.-Plant C
9.14.1 Vianex S.A.-Plant C Pemetrexed Injection Basic Information
9.14.2 Vianex S.A.-Plant C Pemetrexed Injection Product Overview
9.14.3 Vianex S.A.-Plant C Pemetrexed Injection Product Market Performance
9.14.4 Vianex S.A.-Plant C Business Overview
9.14.5 Vianex S.A.-Plant C Recent Developments
9.15 Hainan Jinrui Pharmaceutical
9.15.1 Hainan Jinrui Pharmaceutical Pemetrexed Injection Basic Information
9.15.2 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Overview
9.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Market Performance
9.15.4 Hainan Jinrui Pharmaceutical Business Overview
9.15.5 Hainan Jinrui Pharmaceutical Recent Developments
10 PEMETREXED INJECTION MARKET FORECAST BY REGION
10.1 Global Pemetrexed Injection Market Size Forecast
10.2 Global Pemetrexed Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pemetrexed Injection Market Size Forecast by Country
10.2.3 Asia Pacific Pemetrexed Injection Market Size Forecast by Region
10.2.4 South America Pemetrexed Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pemetrexed Injection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pemetrexed Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pemetrexed Injection by Type (2025-2030)
11.1.2 Global Pemetrexed Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pemetrexed Injection by Type (2025-2030)
11.2 Global Pemetrexed Injection Market Forecast by Application (2025-2030)
11.2.1 Global Pemetrexed Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Pemetrexed Injection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pemetrexed Injection Market Size Comparison by Region (M USD)
Table 5. Global Pemetrexed Injection Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pemetrexed Injection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pemetrexed Injection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pemetrexed Injection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Injection as of 2022)
Table 10. Global Market Pemetrexed Injection Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pemetrexed Injection Sales Sites and Area Served
Table 12. Manufacturers Pemetrexed Injection Product Type
Table 13. Global Pemetrexed Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pemetrexed Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pemetrexed Injection Market Challenges
Table 22. Global Pemetrexed Injection Sales by Type (Kilotons)
Table 23. Global Pemetrexed Injection Market Size by Type (M USD)
Table 24. Global Pemetrexed Injection Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pemetrexed Injection Sales Market Share by Type (2019-2024)
Table 26. Global Pemetrexed Injection Market Size (M USD) by Type (2019-2024)
Table 27. Global Pemetrexed Injection Market Size Share by Type (2019-2024)
Table 28. Global Pemetrexed Injection Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pemetrexed Injection Sales (Kilotons) by Application
Table 30. Global Pemetrexed Injection Market Size by Application
Table 31. Global Pemetrexed Injection Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pemetrexed Injection Sales Market Share by Application (2019-2024)
Table 33. Global Pemetrexed Injection Sales by Application (2019-2024) & (M USD)
Table 34. Global Pemetrexed Injection Market Share by Application (2019-2024)
Table 35. Global Pemetrexed Injection Sales Growth Rate by Application (2019-2024)
Table 36. Global Pemetrexed Injection Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pemetrexed Injection Sales Market Share by Region (2019-2024)
Table 38. North America Pemetrexed Injection Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pemetrexed Injection Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pemetrexed Injection Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pemetrexed Injection Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pemetrexed Injection Sales by Region (2019-2024) & (Kilotons)
Table 43. Eagle Pharmaceuticals Pemetrexed Injection Basic Information
Table 44. Eagle Pharmaceuticals Pemetrexed Injection Product Overview
Table 45. Eagle Pharmaceuticals Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Eagle Pharmaceuticals Business Overview
Table 47. Eagle Pharmaceuticals Pemetrexed Injection SWOT Analysis
Table 48. Eagle Pharmaceuticals Recent Developments
Table 49. AuroMedics Pharma Pemetrexed Injection Basic Information
Table 50. AuroMedics Pharma Pemetrexed Injection Product Overview
Table 51. AuroMedics Pharma Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AuroMedics Pharma Business Overview
Table 53. AuroMedics Pharma Pemetrexed Injection SWOT Analysis
Table 54. AuroMedics Pharma Recent Developments
Table 55. Teva Pharmaceutical Industries Pemetrexed Injection Basic Information
Table 56. Teva Pharmaceutical Industries Pemetrexed Injection Product Overview
Table 57. Teva Pharmaceutical Industries Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Teva Pharmaceutical Industries Pemetrexed Injection SWOT Analysis
Table 59. Teva Pharmaceutical Industries Business Overview
Table 60. Teva Pharmaceutical Industries Recent Developments
Table 61. Taro Pharma Pemetrexed Injection Basic Information
Table 62. Taro Pharma Pemetrexed Injection Product Overview
Table 63. Taro Pharma Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Taro Pharma Business Overview
Table 65. Taro Pharma Recent Developments
Table 66. Seacross Pharmaceuticals Pemetrexed Injection Basic Information
Table 67. Seacross Pharmaceuticals Pemetrexed Injection Product Overview
Table 68. Seacross Pharmaceuticals Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Seacross Pharmaceuticals Business Overview
Table 70. Seacross Pharmaceuticals Recent Developments
Table 71. Simcere Pharmaceutical Group Pemetrexed Injection Basic Information
Table 72. Simcere Pharmaceutical Group Pemetrexed Injection Product Overview
Table 73. Simcere Pharmaceutical Group Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Simcere Pharmaceutical Group Business Overview
Table 75. Simcere Pharmaceutical Group Recent Developments
Table 76. Qilu Pharmaceutical Pemetrexed Injection Basic Information
Table 77. Qilu Pharmaceutical Pemetrexed Injection Product Overview
Table 78. Qilu Pharmaceutical Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Qilu Pharmaceutical Business Overview
Table 80. Qilu Pharmaceutical Recent Developments
Table 81. Pfizer Pemetrexed Injection Basic Information
Table 82. Pfizer Pemetrexed Injection Product Overview
Table 83. Pfizer Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Jiangsu Anda Pharmaceutical Pemetrexed Injection Basic Information
Table 87. Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Overview
Table 88. Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Jiangsu Anda Pharmaceutical Business Overview
Table 90. Jiangsu Anda Pharmaceutical Recent Developments
Table 91. Yangtze River Pharmaceutical Group Pemetrexed Injection Basic Information
Table 92. Yangtze River Pharmaceutical Group Pemetrexed Injection Product Overview
Table 93. Yangtze River Pharmaceutical Group Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Yangtze River Pharmaceutical Group Business Overview
Table 95. Yangtze River Pharmaceutical Group Recent Developments
Table 96. Hansoh Pharmaceutical Group Company Pemetrexed Injection Basic Information
Table 97. Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Overview
Table 98. Hansoh Pharmaceutical Group Company Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hansoh Pharmaceutical Group Company Business Overview
Table 100. Hansoh Pharmaceutical Group Company Recent Developments
Table 101. Nanjing Pharmaceutical Factory Pemetrexed Injection Basic Information
Table 102. Nanjing Pharmaceutical Factory Pemetrexed Injection Product Overview
Table 103. Nanjing Pharmaceutical Factory Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Nanjing Pharmaceutical Factory Business Overview
Table 105. Nanjing Pharmaceutical Factory Recent Developments
Table 106. DEYAO PHARMA Pemetrexed Injection Basic Information
Table 107. DEYAO PHARMA Pemetrexed Injection Product Overview
Table 108. DEYAO PHARMA Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. DEYAO PHARMA Business Overview
Table 110. DEYAO PHARMA Recent Developments
Table 111. Vianex S.A.-Plant C Pemetrexed Injection Basic Information
Table 112. Vianex S.A.-Plant C Pemetrexed Injection Product Overview
Table 113. Vianex S.A.-Plant C Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Vianex S.A.-Plant C Business Overview
Table 115. Vianex S.A.-Plant C Recent Developments
Table 116. Hainan Jinrui Pharmaceutical Pemetrexed Injection Basic Information
Table 117. Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Overview
Table 118. Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Hainan Jinrui Pharmaceutical Business Overview
Table 120. Hainan Jinrui Pharmaceutical Recent Developments
Table 121. Global Pemetrexed Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Pemetrexed Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Pemetrexed Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Pemetrexed Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Pemetrexed Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Pemetrexed Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Pemetrexed Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Pemetrexed Injection Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Pemetrexed Injection Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Pemetrexed Injection Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Pemetrexed Injection Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Pemetrexed Injection Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Pemetrexed Injection Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pemetrexed Injection Market Size Comparison by Region (M USD)
Table 5. Global Pemetrexed Injection Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pemetrexed Injection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pemetrexed Injection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pemetrexed Injection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Injection as of 2022)
Table 10. Global Market Pemetrexed Injection Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pemetrexed Injection Sales Sites and Area Served
Table 12. Manufacturers Pemetrexed Injection Product Type
Table 13. Global Pemetrexed Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pemetrexed Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pemetrexed Injection Market Challenges
Table 22. Global Pemetrexed Injection Sales by Type (Kilotons)
Table 23. Global Pemetrexed Injection Market Size by Type (M USD)
Table 24. Global Pemetrexed Injection Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pemetrexed Injection Sales Market Share by Type (2019-2024)
Table 26. Global Pemetrexed Injection Market Size (M USD) by Type (2019-2024)
Table 27. Global Pemetrexed Injection Market Size Share by Type (2019-2024)
Table 28. Global Pemetrexed Injection Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pemetrexed Injection Sales (Kilotons) by Application
Table 30. Global Pemetrexed Injection Market Size by Application
Table 31. Global Pemetrexed Injection Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pemetrexed Injection Sales Market Share by Application (2019-2024)
Table 33. Global Pemetrexed Injection Sales by Application (2019-2024) & (M USD)
Table 34. Global Pemetrexed Injection Market Share by Application (2019-2024)
Table 35. Global Pemetrexed Injection Sales Growth Rate by Application (2019-2024)
Table 36. Global Pemetrexed Injection Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pemetrexed Injection Sales Market Share by Region (2019-2024)
Table 38. North America Pemetrexed Injection Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pemetrexed Injection Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pemetrexed Injection Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pemetrexed Injection Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pemetrexed Injection Sales by Region (2019-2024) & (Kilotons)
Table 43. Eagle Pharmaceuticals Pemetrexed Injection Basic Information
Table 44. Eagle Pharmaceuticals Pemetrexed Injection Product Overview
Table 45. Eagle Pharmaceuticals Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Eagle Pharmaceuticals Business Overview
Table 47. Eagle Pharmaceuticals Pemetrexed Injection SWOT Analysis
Table 48. Eagle Pharmaceuticals Recent Developments
Table 49. AuroMedics Pharma Pemetrexed Injection Basic Information
Table 50. AuroMedics Pharma Pemetrexed Injection Product Overview
Table 51. AuroMedics Pharma Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AuroMedics Pharma Business Overview
Table 53. AuroMedics Pharma Pemetrexed Injection SWOT Analysis
Table 54. AuroMedics Pharma Recent Developments
Table 55. Teva Pharmaceutical Industries Pemetrexed Injection Basic Information
Table 56. Teva Pharmaceutical Industries Pemetrexed Injection Product Overview
Table 57. Teva Pharmaceutical Industries Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Teva Pharmaceutical Industries Pemetrexed Injection SWOT Analysis
Table 59. Teva Pharmaceutical Industries Business Overview
Table 60. Teva Pharmaceutical Industries Recent Developments
Table 61. Taro Pharma Pemetrexed Injection Basic Information
Table 62. Taro Pharma Pemetrexed Injection Product Overview
Table 63. Taro Pharma Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Taro Pharma Business Overview
Table 65. Taro Pharma Recent Developments
Table 66. Seacross Pharmaceuticals Pemetrexed Injection Basic Information
Table 67. Seacross Pharmaceuticals Pemetrexed Injection Product Overview
Table 68. Seacross Pharmaceuticals Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Seacross Pharmaceuticals Business Overview
Table 70. Seacross Pharmaceuticals Recent Developments
Table 71. Simcere Pharmaceutical Group Pemetrexed Injection Basic Information
Table 72. Simcere Pharmaceutical Group Pemetrexed Injection Product Overview
Table 73. Simcere Pharmaceutical Group Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Simcere Pharmaceutical Group Business Overview
Table 75. Simcere Pharmaceutical Group Recent Developments
Table 76. Qilu Pharmaceutical Pemetrexed Injection Basic Information
Table 77. Qilu Pharmaceutical Pemetrexed Injection Product Overview
Table 78. Qilu Pharmaceutical Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Qilu Pharmaceutical Business Overview
Table 80. Qilu Pharmaceutical Recent Developments
Table 81. Pfizer Pemetrexed Injection Basic Information
Table 82. Pfizer Pemetrexed Injection Product Overview
Table 83. Pfizer Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Jiangsu Anda Pharmaceutical Pemetrexed Injection Basic Information
Table 87. Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Overview
Table 88. Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Jiangsu Anda Pharmaceutical Business Overview
Table 90. Jiangsu Anda Pharmaceutical Recent Developments
Table 91. Yangtze River Pharmaceutical Group Pemetrexed Injection Basic Information
Table 92. Yangtze River Pharmaceutical Group Pemetrexed Injection Product Overview
Table 93. Yangtze River Pharmaceutical Group Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Yangtze River Pharmaceutical Group Business Overview
Table 95. Yangtze River Pharmaceutical Group Recent Developments
Table 96. Hansoh Pharmaceutical Group Company Pemetrexed Injection Basic Information
Table 97. Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Overview
Table 98. Hansoh Pharmaceutical Group Company Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hansoh Pharmaceutical Group Company Business Overview
Table 100. Hansoh Pharmaceutical Group Company Recent Developments
Table 101. Nanjing Pharmaceutical Factory Pemetrexed Injection Basic Information
Table 102. Nanjing Pharmaceutical Factory Pemetrexed Injection Product Overview
Table 103. Nanjing Pharmaceutical Factory Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Nanjing Pharmaceutical Factory Business Overview
Table 105. Nanjing Pharmaceutical Factory Recent Developments
Table 106. DEYAO PHARMA Pemetrexed Injection Basic Information
Table 107. DEYAO PHARMA Pemetrexed Injection Product Overview
Table 108. DEYAO PHARMA Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. DEYAO PHARMA Business Overview
Table 110. DEYAO PHARMA Recent Developments
Table 111. Vianex S.A.-Plant C Pemetrexed Injection Basic Information
Table 112. Vianex S.A.-Plant C Pemetrexed Injection Product Overview
Table 113. Vianex S.A.-Plant C Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Vianex S.A.-Plant C Business Overview
Table 115. Vianex S.A.-Plant C Recent Developments
Table 116. Hainan Jinrui Pharmaceutical Pemetrexed Injection Basic Information
Table 117. Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Overview
Table 118. Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Hainan Jinrui Pharmaceutical Business Overview
Table 120. Hainan Jinrui Pharmaceutical Recent Developments
Table 121. Global Pemetrexed Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Pemetrexed Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Pemetrexed Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Pemetrexed Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Pemetrexed Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Pemetrexed Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Pemetrexed Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Pemetrexed Injection Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Pemetrexed Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Pemetrexed Injection Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Pemetrexed Injection Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Pemetrexed Injection Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Pemetrexed Injection Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Pemetrexed Injection Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pemetrexed Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pemetrexed Injection Market Size (M USD), 2019-2030
Figure 5. Global Pemetrexed Injection Market Size (M USD) (2019-2030)
Figure 6. Global Pemetrexed Injection Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pemetrexed Injection Market Size by Country (M USD)
Figure 11. Pemetrexed Injection Sales Share by Manufacturers in 2023
Figure 12. Global Pemetrexed Injection Revenue Share by Manufacturers in 2023
Figure 13. Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pemetrexed Injection Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pemetrexed Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pemetrexed Injection Market Share by Type
Figure 18. Sales Market Share of Pemetrexed Injection by Type (2019-2024)
Figure 19. Sales Market Share of Pemetrexed Injection by Type in 2023
Figure 20. Market Size Share of Pemetrexed Injection by Type (2019-2024)
Figure 21. Market Size Market Share of Pemetrexed Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pemetrexed Injection Market Share by Application
Figure 24. Global Pemetrexed Injection Sales Market Share by Application (2019-2024)
Figure 25. Global Pemetrexed Injection Sales Market Share by Application in 2023
Figure 26. Global Pemetrexed Injection Market Share by Application (2019-2024)
Figure 27. Global Pemetrexed Injection Market Share by Application in 2023
Figure 28. Global Pemetrexed Injection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pemetrexed Injection Sales Market Share by Region (2019-2024)
Figure 30. North America Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pemetrexed Injection Sales Market Share by Country in 2023
Figure 32. U.S. Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pemetrexed Injection Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pemetrexed Injection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pemetrexed Injection Sales Market Share by Country in 2023
Figure 37. Germany Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pemetrexed Injection Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pemetrexed Injection Sales Market Share by Region in 2023
Figure 44. China Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pemetrexed Injection Sales and Growth Rate (Kilotons)
Figure 50. South America Pemetrexed Injection Sales Market Share by Country in 2023
Figure 51. Brazil Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pemetrexed Injection Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pemetrexed Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pemetrexed Injection Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pemetrexed Injection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pemetrexed Injection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pemetrexed Injection Market Share Forecast by Type (2025-2030)
Figure 65. Global Pemetrexed Injection Sales Forecast by Application (2025-2030)
Figure 66. Global Pemetrexed Injection Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Pemetrexed Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pemetrexed Injection Market Size (M USD), 2019-2030
Figure 5. Global Pemetrexed Injection Market Size (M USD) (2019-2030)
Figure 6. Global Pemetrexed Injection Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pemetrexed Injection Market Size by Country (M USD)
Figure 11. Pemetrexed Injection Sales Share by Manufacturers in 2023
Figure 12. Global Pemetrexed Injection Revenue Share by Manufacturers in 2023
Figure 13. Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pemetrexed Injection Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pemetrexed Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pemetrexed Injection Market Share by Type
Figure 18. Sales Market Share of Pemetrexed Injection by Type (2019-2024)
Figure 19. Sales Market Share of Pemetrexed Injection by Type in 2023
Figure 20. Market Size Share of Pemetrexed Injection by Type (2019-2024)
Figure 21. Market Size Market Share of Pemetrexed Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pemetrexed Injection Market Share by Application
Figure 24. Global Pemetrexed Injection Sales Market Share by Application (2019-2024)
Figure 25. Global Pemetrexed Injection Sales Market Share by Application in 2023
Figure 26. Global Pemetrexed Injection Market Share by Application (2019-2024)
Figure 27. Global Pemetrexed Injection Market Share by Application in 2023
Figure 28. Global Pemetrexed Injection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pemetrexed Injection Sales Market Share by Region (2019-2024)
Figure 30. North America Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pemetrexed Injection Sales Market Share by Country in 2023
Figure 32. U.S. Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pemetrexed Injection Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pemetrexed Injection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pemetrexed Injection Sales Market Share by Country in 2023
Figure 37. Germany Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pemetrexed Injection Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pemetrexed Injection Sales Market Share by Region in 2023
Figure 44. China Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pemetrexed Injection Sales and Growth Rate (Kilotons)
Figure 50. South America Pemetrexed Injection Sales Market Share by Country in 2023
Figure 51. Brazil Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pemetrexed Injection Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pemetrexed Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pemetrexed Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pemetrexed Injection Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pemetrexed Injection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pemetrexed Injection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pemetrexed Injection Market Share Forecast by Type (2025-2030)
Figure 65. Global Pemetrexed Injection Sales Forecast by Application (2025-2030)
Figure 66. Global Pemetrexed Injection Market Share Forecast by Application (2025-2030)
